Description

Clopixol-depo (Zuclopenthixol) Solution for Injections Ampoules 200 mg. 1ml. №10

Ingredients:

Each ampoule contains 200 mg of zuclopenthixol in 1ml solution for injections.

Dosage:

The dosage and administration should be determined by a healthcare professional. Typically, the recommended dose is administered via deep intramuscular injection.

Indications:

Clopixol-depo is indicated for the treatment of schizophrenia and other psychoses. It helps in managing symptoms such as hallucinations, delusions, and disorganized thinking.

Contraindications:

Do not use Clopixol-depo in patients with known hypersensitivity to zuclopenthixol or any of the ingredients. It is contraindicated in patients with CNS depression, comatose states, and blood dyscrasias.

Directions:

Administer Clopixol-depo strictly as directed by a healthcare provider. The injection should be given deeply into the muscle, and the injection site should be alternated.

Scientific Evidence:

Zuclopenthixol, the active ingredient in Clopixol-depo, exerts its antipsychotic effects by blocking dopamine receptors in the brain. Studies have shown that zuclopenthixol is effective in reducing the positive symptoms of schizophrenia, such as hallucinations and delusions.

Additional Information:

Clopixol-depo has been well-studied in clinical trials for its efficacy and safety in the treatment of schizophrenia. It offers a convenient long-acting formulation that can improve medication adherence and long-term outcomes for patients.

Compared to other antipsychotic medications, Clopixol-depo has shown comparable effectiveness with a potentially lower risk of side effects. This makes it a valuable option in the management of psychotic disorders.